Public institutions conducted nearly 10,000 investigations in April, with the electronic medicine industry dominating the rankings.

April is a key month for the disclosure of annual reports and first-quarter reports of A-share listed companies, and public institutions are conducting research intensively. According to the latest data from the public fund ranking website, a total of 162 public institutions conducted research on A-share listed companies in April, covering 732 individual stocks in 30 Shenwan first-level industries. The total number of research visits reached 9796 times, a significant increase of 129.47% compared to March, setting a new high for research activity this year. The electronics and pharmaceutical biotechnology industries are leading in research data. Among the top ten stocks in terms of public fund research visits in April, the electronics industry holds four seats, with Luxshare Precision ranking first, followed by Shanghai Electric Power, Lianqi Technology, and Anker Innovation. In the pharmaceutical sector, stocks such as Huadong Medicine, Aibao Medical, Aopumai, and Kaili Medical received attention.